Caspase-dependent Cdk activity is a requisite effector of apoptotic death events

Related Experiment Video

Updated: Oct 18, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

K J Harvey1, D Lukovic, D S Ucker

  • 1Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, Illinois 60612, USA.

The Journal of Cell Biology
|January 12, 2000
PubMed

Insights

Cyclin-dependent kinase 2 (Cdk2) activity is essential for apoptotic cell death, acting downstream of caspases. Caspase activation initiates but does not solely execute cell death, requiring Cdk2 for key apoptotic events.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Caspase activation is a hallmark of apoptosis, but its precise role in executing cell death remains incompletely understood.
  • Cyclin-dependent kinases (Cdks) are known regulators of the cell cycle and have been implicated in cell death pathways.
  • The interplay between caspases and Cdks in apoptosis requires further elucidation.

Purpose of the Study:

  • To investigate the functional role of Cdk activity in executing apoptosis.
  • To determine the position of Cdk activation relative to the caspase cascade in the cell death pathway.
  • To dissect the specific apoptotic events dependent on Cdk activity.

Main Methods:

  • Genetic manipulation using dominant-negative Cdk mutants (DN-Cdks) and Cdk inhibitory genes.
  • Assessment of apoptotic morphological and biochemical features (chromatin condensation, cell shrinkage, substrate adhesion loss).
  • Direct visualization of active caspase activity and measurement of mitochondrial membrane potential and phospholipid asymmetry.

Main Results:

  • Cdk2 activity is indispensable for chromatin condensation, cell shrinkage, and loss of adhesion during apoptosis.
  • Inhibition of Cdk2 activity does not impede caspase cascade activation or early death events like loss of mitochondrial potential.
  • Caspase activity is upstream of Cdk2 activation, indicating Cdk2 acts as an effector downstream of caspases.

Conclusions:

  • Caspase activity is necessary but not sufficient for the complete execution of apoptosis.
  • Caspase activation leads to the activation of effector Cdks, specifically Cdk2, which are required for key apoptotic morphological changes.
  • This study identifies a critical downstream role for Cdk2 in the execution phase of apoptosis, downstream of caspase activation.

More Related Videos

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...